23.81k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
Watchlist | Change today | 1-month return | 1-year return | Total return |
---|---|---|---|---|
The fight against COVID19 | +1.51% | - | - | - |
^GSPC | +1.20% | -2.83% | +22.56% | +5352.20% |
Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
---|---|---|---|---|---|---|---|---|
JNJ | Johnson & Johnson | 149.56 | +0.44 | +0.30% | 4:00 pm GMT-4 | 9.68M | 7.52M | 360.41B |
ABBV | AbbVie Inc. | 169.54 | +1.65 | +0.98% | 4:00 pm GMT-4 | 3.94M | 5.65M | 300.20B |
PFE | Pfizer Inc. | 26.32 | +0.06 | +0.23% | 4:00 pm GMT-4 | 23.80M | 42.88M | 149.04B |
SNY | Sanofi | 47.69 | +0.54 | +1.15% | 4:00 pm GMT-4 | 1.66M | 1.96M | 119.06B |
REGN | Regeneron Pharmaceuticals, Inc. | 907.32 | +7.16 | +0.80% | 4:00 pm GMT-4 | 340.94k | 465.71k | 99.59B |
GSK | GSK plc | 41.24 | +0.65 | +1.60% | 4:00 pm GMT-4 | 2.29M | 3.58M | 84.25B |
GILD | Gilead Sciences, Inc. | 67.03 | +0.08 | +0.12% | 4:00 pm GMT-4 | 5.23M | 7.23M | 83.58B |
TAK | Takeda Pharmaceutical Company Limited | 13.38 | +0.02 | +0.15% | 4:00 pm GMT-4 | 1.70M | 1.84M | 41.98B |
MRNA | Moderna, Inc. | 107.89 | +3.43 | +3.28% | 4:00 pm GMT-4 | 2.43M | 3.77M | 41.31B |
BNTX | BioNTech SE | 88.49 | +0.48 | +0.55% | 4:00 pm GMT-4 | 359.34k | 636.60k | 21.33B |
VIR | Vir Biotechnology, Inc. | 8.13 | +0.03 | +0.37% | 4:00 pm GMT-4 | 762.45k | 1.08M | 1.10B |
NVAX | Novavax, Inc. | 4.19 | +0.12 | +2.95% | 4:00 pm GMT-4 | 3.58M | 7.33M | 586.40M |
INO | Inovio Pharmaceuticals, Inc. | 10.37 | +0.35 | +3.49% | 4:00 pm GMT-4 | 241.97k | 496.89k | 268.65M |
Editor’s note: We have updated the story with Kenvue’s statement in response to the report in paragraph 7 The World Health Organization (WHO) is poised to issue a broader alert regarding contaminated children’s cough syrup produced by Johnson and Johnson (NYSE:JNJ) in response to the discovery of tainted batches in Nigeria. Last week, Nigeria’s regulatory body recalled a specific batch of Benylin syrup after detecting elevated levels of diethylene glycol during routine testing, Reuters reports.
“We believe earnings growth is set for a healthier runway through 2024,” Morgan Stanley’s analysts wrote.
(Bloomberg) -- French drugmaker Sanofi has asked banks to pitch for roles on the separation of its consumer-health business, according to people familiar with the matter, one of the biggest deals likely to happen in Europe this year. Most Read from BloombergTaylor Swift Is Proof That How We Critique Music Is BrokenTesla Stock in ‘No Man’s Land’ After 43% Rout Ahead of EarningsTech Giants Roar as Tesla Spikes in Late Hours: Markets WrapRay Dalio’s Famous Trade Is Sputtering, Investors BailingBill